Blurry tennis court background

Developing Regenerative Therapies that Reverse Chronic Disease

Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of cell therapies designed to reverse disease and promote the regeneration of damaged tissue.

Learn more about our approach
senior tennis player
Cell rendering up close
scientific data icon

Mission-Driven Science

Our proprietary CD34+ cell therapy platform has generated a multi-product development pipeline with the potential to provide curative therapies to people in need. 

Doctor is using a stethoscope for patients patient examination
lightbulb icon


Caladrius is a national supporter of the American Heart Association’s Go Red for Women® Movement and its efforts to raise awareness around coronary microvascular dysfunction (CMD) – a disease that is often misdiagnosed and disproportionately afflicts women. Click the link below to read more about CMD from Dr. Harmony R. Reynolds, Director of the Sarah Ross Soter Center for Women’s Cardiovascular Research at NYU Langone Health.

Visualization of the heart vessels
Monitor Showing EKG Reading
electrocardiogram close up
publication icon



CD34+ Cell Therapy Significantly Reduces Adverse Cardiac Events, Health Care Expenditures, and Mortality in Patients with Refractory Angina

Testing for Coronary Microvascular Dysfunction

Autologous CD34+ Cell Therapy for Ischemic Tissue Repair


Recent News

Join Our Team

Our mission is to discover, develop and deliver innovative therapeutics in areas of unmet medical need that improve patient lives. We can accomplish that goal through the collective efforts of talented individuals who work together to advance scientific research. We place a premium on integrity, respect, diversity and collaboration. These values have helped us to build a growing company that offers professionally rewarding careers with the opportunity to make a meaningful contribution to patients in need. 

Audience Applauding Speaker After Conference Presentation